Format

Send to

Choose Destination
Biochim Biophys Acta. 2010 Aug;1801(8):930-3. doi: 10.1016/j.bbalip.2010.01.009. Epub 2010 Jan 29.

The neurobiology of isoprostanes and Alzheimer's disease.

Author information

1
Department of Pharmacology, Temple University, School of Medicine, Philadelphia, PA 19140, USA. praticod@temple.edu

Abstract

In its sporadic form Alzheimer's disease (AD) results from a combination of genetic and environmental risk factors with abnormal oxidative reactions, which result in free radical mediated injury of the brain. Isoprostanes are oxidized lipids formed by a free radical mediated mechanism, which in recent years have emerged as a reliable and sensitive marker of lipid peroxidation and oxidative stress. Consistent data show that they are increased in the brain of human AD as well as AD animal models. Besides their role as biomarkers, isoprostanes possess important biological effects, functioning as mediators of the cellular response to oxidative stress within the CNS. Recent evidence indicates that these lipid oxidation products, by activating the thromboxane receptor system, mediate the pro-amyloidotic neuronal response to oxidative stress in an experimental model of AD. This novel observation has important clinical implication, since pharmacologic modulation of the TP receptor system by selective antagonists, some of which are already available, could represent a novel therapeutic opportunity for AD as disease-modifying agents.

PMID:
20116452
DOI:
10.1016/j.bbalip.2010.01.009
[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for Elsevier Science
Loading ...
Support Center